Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy flag Italy · Delayed Price · Currency is EUR
52.70
+0.20 (0.38%)
Aug 17, 2026, 11:37 AM CET

BIT:REC Revenue

Recordati Industria Chimica e Farmaceutica had revenue of 697.36M EUR in the quarter ending June 30, 2026, with 8.30% growth. This brings the company's revenue in the last twelve months to 2.71B, up 9.10% year-over-year. In the year 2025, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.62B with 11.82% growth.

Revenue (ttm)
2.71B
Revenue Growth
+9.10%
P/S Ratio
3.97
Revenue / Employee
581.29K
Employees
4,693
Market Cap
10.75B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.62B276.82M11.82%
Dec 31, 20242.34B259.23M12.45%
Dec 31, 20232.08B229.02M12.36%
Dec 31, 20221.85B273.23M17.29%
Dec 31, 20211.58B131.21M9.06%
Dec 31, 20201.45B-32.98M-2.23%
Dec 31, 20191.48B129.61M9.59%
Dec 31, 20181.35B64.11M4.98%
Dec 31, 20171.29B134.18M11.63%
Dec 31, 20161.15B106.27M10.14%
Dec 31, 20151.05B60.32M6.11%
Dec 31, 2014987.36M45.73M4.86%
Dec 31, 2013941.63M113.31M13.68%
Dec 31, 2012828.32M66.28M8.70%
Dec 31, 2011762.04M33.90M4.66%
Dec 31, 2010728.13M-19.39M-2.59%
Dec 31, 2009747.52M57.89M8.39%
Dec 31, 2008689.63M61.20M9.74%
Dec 31, 2007628.44M52.25M9.07%
Dec 31, 2006576.19M106.00K0.02%
Dec 31, 2005576.08M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Amplifon2.40B
DiaSorin1.18B
Safilo Group957.72M
EL.En.595.51M
GPI S.p.A.546.18M
Garofalo Health Care489.26M
Philogen319.73M
Svas Biosana141.56M
Revenue Rankings